Number of patients that are able to be weaned off all third-line agents prior to the end of the SAGE-547 or placebo infusion, and remain off all third-line agents for = 24 hours following the end of the SAGE-547 or placebo infusion

Grants and Contracts Details

StatusFinished
Effective start/end date7/13/154/18/18

Funding

  • Sage Therapeutics Incorporated: $16,711.00